Ether

Ether

SCHEMBL3701805

CCOCC.F[B-](F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL1637115 1.00 ALDH1A1 (0.37) ALDH1A1
Ether SCHEMBL8985216 0.96 ALDH1A1 (0.35) ALDH1A1
Ether SCHEMBL265707 0.96 ALDH1A1 (0.35) ALDH1A1
Ether SCHEMBL27348478 0.82
SCHEMBL27315915 0.82 ALDH1A1 (0.32) ALDH1A1
Ether SCHEMBL21406 0.82 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL9248674 0.82 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL6 0.82
Ether SCHEMBL9248046 0.82 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL8160191 0.82 ALDH1A1 (0.47) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179331-B2 Ligand based chromium catalyst and application in catalyzing ethylene oligomerization CHINA PETROLEUM & CHEIMCAL CORPORATION (CN) 2019-01-15 US claimed
US-20170106358-A1 LIGAND BASED CHROMIUM CATALYST AND APPLICATION IN CATALYZING ETHYLENE OLIGOMERIZATION XIAMEN UNIVERSITY (CN) 2017-04-20 US claimed
US-4224241-A Production of halogenomethylphosphinic acid halides HOECHST AKTIENGESELLSCHAFT (DE) 1980-09-23 US claimed
CN-117980293-A Hydroxamic acid compound with ENPP1 inhibitory activity and application thereof 上海海和药物研究开发股份有限公司 2024-05-03 CN disclosed
CN-117956985-A Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof 梅兹治疗公司 2024-04-30 CN disclosed
CN-117447441-A Difluoromethyl reagent and preparation method and application thereof 深圳大学 2024-01-26 CN disclosed
WO-2023249800-A1 POLYURETHANE PRODUCTS WITH DIGITAL FUNCTIONALITY THROUGH USE OF EMBEDDED SENSOR DEVICES BASF SE (DE) 2023-12-28 WO disclosed
CN-117295744-A Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing raw material therefor 明治制果药业株式会社 2023-12-26 CN disclosed
CN-111592644-B Ring-opening polymerization method for cyclic monomer 南京工业大学 2023-03-28 CN disclosed
CN-115417999-A One-dimensional polyrotaxane constructed based on coordinated boron-nitrogen bond and preparation method and application thereof 浙江大学杭州国际科创中心 2022-12-02 CN disclosed
CN-114471718-A Catalytic system for ethylene selective oligomerization and ethylene selective oligomerization method 中国石油天然气股份有限公司 2022-05-13 CN disclosed
US-4224241-A Production of halogenomethylphosphinic acid halides HOECHST AKTIENGESELLSCHAFT (DE) 1980-09-23 US disclosed
US-4194047-A Substituted N-methylene derivatives of thienamycin MERCK & CO., INC. (US) 1980-03-18 US disclosed
EP-0001264-A1 Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation MERCK & CO. INC. (US) 1979-04-04 EP disclosed
US-4144123-A EPICHLOROHYDRIN DERIVATIVE OF POLYETHER AS CROSSLINKER BASF AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed
US-4066494-A NITROGENOUS CONDENSATION PRODUCTS USED AS RETENTION AIDS IN PAPERMAKING BASF AKTIENGESELLSCHAFT (DT) 1978-01-03 US disclosed
US-4052216-A REDUCE FADING OF IMAGE DYE AGFA-GEVAERT, A.G. (DT) 1977-10-04 US disclosed
US-4049377-A WATER, DISPERSE DYE, SOLVENT, N-HYDROXYALKYL AMIDES BASF AKTIENGESELLSCHAFT (DT) 1977-09-20 US disclosed
US-RE28972-E SEDATIVES, ANTICONVULSANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-09-21 US disclosed
US-3954889-A Process for the production of 1,1,3,3-substituted hydroxyindanes BAYER AKTIENGESELLSCHAFT (DT) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170106358-A1 LIGAND BASED CHROMIUM CATALYST AND APPLICATION IN CATALYZING ETHYLENE OLIGOMERIZATION CHRNE, NOD2, NOD1 ALDH1A1 4562/4885
US-10179331-B2 Ligand based chromium catalyst and application in catalyzing ethylene oligomerization CHRNE, NOD2, NOD1 ALDH1A1 4562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.